Actively Recruiting
International Prospective Registry on Local Treatment Approaches in MLS
Led by The Netherlands Cancer Institute · Updated on 2022-08-30
300
Participants Needed
1
Research Sites
519 weeks
Total Duration
On this page
Sponsors
T
The Netherlands Cancer Institute
Lead Sponsor
R
Radboud University Medical Center
Collaborating Sponsor
AI-Summary
What this Trial Is About
To prospectively study commonly used local treatment approaches in Myxoid Liposarcoma (MLS)
CONDITIONS
Official Title
International Prospective Registry on Local Treatment Approaches in MLS
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age > 18 years
- Biopsy proven Myxoid Liposarcoma, including the reciprocal chromosomal translocation t(12;16)(q13;p11)
- ECOG performance status 0-2
- Written informed consent to share coded information in this international Registry
You will not qualify if you...
- Prior radiotherapy to the target area
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Netherlands Cancer Institute
Amsterdam, Netherlands, 1066CX
Actively Recruiting
Research Team
R
Rick Haas, MD/PhD
CONTACT
J
Jules Lansu, MD/PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
5
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here